Trial Profile
ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Eritoran (Primary)
- Indications Sepsis
- Focus Registrational; Therapeutic Use
- Acronyms ACCESS
- Sponsors Eisai Inc
- 03 Sep 2014 New trial record